Hiroko Takenouchi

839 citations
11 papers · 404 indexed · h-index 10
Topics
Immunotherapy and Immune Responses (4 papers)Cancer Immunotherapy and Biomarkers (4 papers)MicroRNA in disease regulation (3 papers)
Partner nations
JapanUnited StatesEgypt

In The Last Decade

Hiroko Takenouchi

11 papers receiving 402 citations

Peers

Hiroko Takenouchi
Comparison fields: 5 of 59
  • Oncology 229
  • Molecular Biology 196
  • Cancer Research 132
  • Immunology 101
  • Biomedical Engineering 47
Replace Hsin-Wei Liao with:
Hsin-Wei Liao United States
Elmira Gheytanchi Iran
Hajar Alemohammad Iran
Kelly DuPree United States
Anette Heller Germany
Yuichi Ohnishi Japan
Basira Najafzadeh Iran
Qike Huang China
Size Chen China
Elham Alsahafi Saudi Arabia
Hiroko Takenouchi relative to Hsin-Wei Liao United States Hsin-Wei Liao's profile →
Citations per field
00.5×1.5×2.1×
Hsin-Wei Liao · 1×
Citations per year

Countries citing papers authored by Hiroko Takenouchi

Since Specialization
Citations

This map shows the geographic impact of Hiroko Takenouchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Takenouchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Takenouchi more than expected).

Fields of papers citing papers by Hiroko Takenouchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Takenouchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Takenouchi. The network helps show where Hiroko Takenouchi may publish in the future.

Co-authorship network of co-authors of Hiroko Takenouchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Takenouchi. A scholar is included among the top collaborators of Hiroko Takenouchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Takenouchi. Hiroko Takenouchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 42
2 39
3 27
4 80
5 17
6 42
7 34
8 33
9 23
10 66
11 1

About Hiroko Takenouchi

Hiroko Takenouchi is a scholar working on Oncology, Cancer Research and Immunology, having authored 11 papers that have together received 404 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (132 citations), Oncology (229 citations) and Immunology (101 citations). Hiroko Takenouchi has collaborated with scholars based in Japan, United States and Egypt. Frequent co-authors include Shoichi Hazama, Nobuaki Suzuki, Ryouichi Tsunedomi, Hiroaki Nagano, Shigefumi Yoshino, Yuka Inoue, Masao Nakajima, Koichi Sato, Masashi Sakurai and Hideyuki Yamawaki. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026